This clinical condition is seen in
**Core Concept**
The condition in question is a rare but serious complication of diabetes mellitus, characterized by the accumulation of amylin precursor protein (APP) in the pancreas, leading to pancreatic islet amyloidosis and subsequent beta-cell dysfunction.
**Why the Correct Answer is Right**
This condition is seen in type 2 diabetes mellitus, particularly in long-standing cases. The accumulation of amylin precursor protein (APP) in the pancreas leads to the formation of amyloid fibrils, which deposit in the islets of Langerhans and disrupt the normal architecture and function of the beta-cells. This results in impaired insulin secretion and worsened glycemic control.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because the condition is not typically associated with type 1 diabetes mellitus, which is characterized by a distinct autoimmune pathogenesis.
* **Option B:** This option is incorrect because the condition is not primarily caused by a genetic mutation, although genetic factors may contribute to the risk of developing type 2 diabetes.
* **Option C:** This option is incorrect because the condition is not a direct result of pancreatic inflammation or infection.
**Clinical Pearl / High-Yield Fact**
It's essential to recognize the importance of amylin precursor protein (APP) accumulation in the pathogenesis of type 2 diabetes mellitus, particularly in long-standing cases. This knowledge can inform the management of patients with type 2 diabetes, including the potential use of amylin analogs as therapeutic agents.
**Correct Answer:** D.